Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in Iterum Therapeutics plc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −4 vs. Q3 2025
- Shares held
- 1.67M
- +314.8K (+23.3%) vs. Q3 2025
- Total value
- $557.9K
- −$346.2K (−38.3%) vs. Q3 2025
- New holders
- 3
- 5 more added
- Sold out
- 7
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 16 | $5 | 0.00% | 00.0% | Unchanged |
| Blue Bell Private Wealth Management, LLC | 66 | $22 | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 66 | $22 | 0.00% | 00.0% | Unchanged |
| Robinswood Financial LLC | 66 | $22 | 0.00% | +66 | New |
| Wells Fargo & Company | 85 | $28 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 133 | $45 | 0.00% | 00.0% | Unchanged |
| Medallion Wealth Advisors, LLC | 1,680 | $563 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,713 | $1.91K | 0.00% | −2,900−33.7% | Reduced |
| SG Americas Securities, LLC | 12,782 | $4.00K | 0.00% | −4,038−24.0% | Reduced |
| Geode Capital Management, LLC | 12,370 | $4.14K | 0.00% | 00.0% | Unchanged |
| Sanctuary Advisors, LLC | 20,000 | $6.70K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 20,477 | $6.86K | 0.01% | +20,477 | New |
| Virtu Financial LLC | 22,062 | $7.00K | 0.00% | −25,069−53.2% | Reduced |
| Krilogy Financial LLC | 40,000 | $13.4K | 0.00% | 00.0% | Unchanged |
| Gen-Wealth Partners Inc | 84,630 | $28.4K | 0.01% | +2,583+3.1% | Added |
| UBS Group AG | 119,948 | $40.2K | 0.00% | +111,322+1,290.5% | Added |
| Captrust Financial Advisors | 138,600 | $46.4K | 0.00% | +27,000+24.2% | Added |
| Alchemi Wealth, LLC | 268,886 | $90.1K | 0.05% | +268,886 | New |
| Jane Street Group, LLC | 289,410 | $97.0K | 0.00% | +274,892+1,893.5% | Added |
| Apollon Financial, LLC | 630,250 | $211.1K | 0.03% | +380,000+151.8% | Added |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −443,972−100.0% | Sold out |
| Resources Investment Advisors, LLC. | 0 | $0 | 0.00% | −191,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −81,694−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,701−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| GGM Financials LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |